A New Era in Oncology: Tennessee's $20 Million Leap into Radiopharmaceutical Research
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Recurrent Colorectal Carcinoma
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00531
Cyclophosphamide
1
Terminated
1
DB00091
Cyclosporine
1
Active Not Recruiting
1
DB00099
Filgrastim
1
Terminated
1
DB12303
Motolimod
1
Terminated
1
DB00019
Pegfilgrastim
1
Terminated
1
DB09037
Pembrolizumab
1
Completed
1
DB15185
Rasdegafusp alfa
1
Completed
1
DB06176
Romidepsin
1
Active Not Recruiting
1
DB11689
Selumetinib
1
Active Not Recruiting
1
DB00877
Sirolimus
1
Completed
1
DB12981
XL-888
1
Completed
1
DB12001
Abemaciclib
1 / 2
Active Not Recruiting
1
DB00855
Aminolevulinic acid
1 / 2
Not Yet Recruiting
1
DB00002
Cetuximab
1 / 2
Active Not Recruiting
1
DB00002
Cetuximab
1 / 2
Completed
1
DB00002
Cetuximab
1 / 2
Recruiting
1
DB11718
Encorafenib
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Recruiting
1
DB09037
Pembrolizumab
1 / 2
Completed
1
DB18442
ABSK-091
2
Active Not Recruiting
1
DB11740
Adavosertib
2
Active Not Recruiting
1
DB08916
Afatinib
2
Active Not Recruiting
1
DB11595
Atezolizumab
2
Active Not Recruiting
1
DB11105
Benzalkonium
2
Completed
1
DB00112
Bevacizumab
2
Active Not Recruiting
1
DB11967
Binimetinib
2
Active Not Recruiting
1
DB01373
Calcium
2
Terminated
1
DB04690
Camptothecin
2
Terminated
1
DB01101
Capecitabine
2
Active Not Recruiting
1
DB12218
Capivasertib
2
Active Not Recruiting
1
DB00482
Celecoxib
2
Completed
1
DB12483
Copanlisib
2
Active Not Recruiting
1
DB08865
Crizotinib
2
Active Not Recruiting
1
DB08912
Dabrafenib
2
Active Not Recruiting
1
DB01254
Dasatinib
2
Active Not Recruiting
1
DB12282
Defactinib
2
Active Not Recruiting
1
DB12147
Erdafitinib
2
Active Not Recruiting
1
DB00693
Fluorescein
2
Terminated
1
DB00544
Fluorouracil
2
Terminated
1
DB11795
GSK-2636771
2
Active Not Recruiting
1
DB05258
Interferon alfa
2
Completed
1
DB00105
Interferon alfa-2b
2
Completed
1
DB11743
Ipatasertib
2
Active Not Recruiting
1
DB00762
Irinotecan
2
Terminated
1
DB00762
Irinotecan
2
Unknown Status
1
DB14723
Larotrectinib
2
Active Not Recruiting
1
DB00650
Leucovorin
2
Terminated
1
DB11596
Levoleucovorin
2
Terminated
1
DB15994
Methane
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09330
Osimertinib
2
Active Not Recruiting
1
DB00892
Oxybuprocaine
2
Terminated
1
DB09073
Palbociclib
2
Active Not Recruiting
1
DB01269
Panitumumab
2
Terminated
1
DB09037
Pembrolizumab
2
Not Yet Recruiting
1
DB06366
Pertuzumab
2
Active Not Recruiting
1
DB00293
Raltitrexed
2
Unknown Status
1
DB16364
Recombinant Human Thrombopoietin
2
Unknown Status
1
DB14851
Relatlimab
2
Active Not Recruiting
1
DB16425
Rintatolimod
2
Completed
1
DB11836
Sapanisertib
2
Active Not Recruiting
1
DB14546
Sulfate ion
2
Active Not Recruiting
1
DB01268
Sunitinib
2
Active Not Recruiting
1
DB12108
Taselisib
2
Active Not Recruiting
1
DB08911
Trametinib
2
Active Not Recruiting
1
DB00072
Trastuzumab
2
Active Not Recruiting
1
DB05773
Trastuzumab emtansine
2
Active Not Recruiting
1
DB00135
Tyrosine
2
Active Not Recruiting
1
DB13930
Ulixertinib
2
Active Not Recruiting
1
DB08828
Vismodegib
2
Active Not Recruiting
1